AOD-9604 is a peptide derived from human growth hormone that targets fat reduction without impacting blood glucose levels or causing significant side effects
(2021) human knee study used intra-articular injection (directly into the joint space), which requires clinical supervision
use within 4 weeks for optimal stability
Check the Current BPC-157 Price at BioInfinity References Gwyer D, Wragg NM, Wilson SL
If your symptoms strongly suggest deficiency and you have risk factors like being over 50, following a restricted diet, or having digestive conditions, we can proceed with treatment while recommending you arrange a blood test with your GP for confirmation
Compounded medications are only indicated for patients when a prescribing practitioner determines that the compounded preparation produces a significant difference for their patient compared to the FDA-approved product